Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01942824 · ClinicalTrials.gov registry record · NA

Adult Influenza Vaccination Text Message Reminders

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
7,250
Enrollment target

NCT01942824: Completed NA study, sponsored by Columbia University.

NCT01942824 is a NA study that has completed, run by Columbia University. The registered enrollment target is 7,250 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (417% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01942824, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
7,250 participants
Enrollment target

Study Summary

Influenza infection leads to on average 24,0000 deaths and 150,000 hospitalizations annually. While vaccination is the cornerstone of preventing influenza infection, vaccination coverage in adults is low with only 35% vaccinated by end of November. Latino adults have the lowest coverage rates. Text message reminders have been used successfully for improving influenza vaccination for children. This study will assess the use of text messaging to improve influenza vaccination coverage rates in a largely minority, publicly insured adult population.

Primary Outcome

Days from start of intervention to vaccination

Interventions

  • BEHAVIORAL Text Messages

Trial Details

FieldValue
Enrollment Target 7,250 participants
Start Date 2013-09
Est. Completion 2014-05
Phase NA
Columbia University

958 total trials

What the finished NCT01942824 record still lists

NCT01942824 is an interventional study that assigns participants to a tested intervention. Its 7,250 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (417% higher).

The record links to 0 conditions, and to 1 intervention - of which Text Messages is the first listed.

NCT01942824 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01942824 about?

NCT01942824 is a clinical study titled "Adult Influenza Vaccination Text Message Reminders". Influenza infection leads to on average 24,0000 deaths and 150,000 hospitalizations annually. While vaccination is the cornerstone of preventing influenza infection, vaccination coverage in adults is low with only 35% vaccinated by end of November. Latino adults have the lowest coverage rates. Text ...

What is the current status of trial NCT01942824?

This trial is currently completed. It is a NA study. The enrollment target is 7,250 participants. The study started on 2013-09. Estimated completion is 2014-05.

What interventions are being tested in trial NCT01942824?

The interventions under investigation include: Text Messages (BEHAVIORAL).

Who is sponsoring clinical trial NCT01942824?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01942824's enrollment target sits among peer trials

7,250 20th of 2000 higher than 1,981 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05049837 · 7,200 participants

    PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification

  • NCT06714929 · 7,200 participants · NA

    Advancing Water Security: A Community Participatory School-Based Hydration Intervention

  • NCT06843720 · 7,100 participants · NA

    Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems

  • NCT02915198 · 7,410 participants · Phase 4

    Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01942824, the US trial registry maintained by the National Library of Medicine. NCT01942824 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.